Scoping out a new diabetes fix: endoscopic procedure aims to regenerate gut lining
NCT ID NCT04725890
Summary
This study tested the safety and feasibility of a new endoscopic procedure called DyaMX for people with type 2 diabetes. The procedure aims to regenerate the lining of the duodenum (the first part of the small intestine) to help improve blood sugar control. 65 adults whose diabetes was not well-controlled on their current medications underwent the procedure and were followed for 48 weeks to check for safety and changes in blood sugar levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
St Vincent's Hospital Melbourne
Fitzroy, Victoria, VIC 3065, Australia
-
The BMI Clinic
Sydney, New South Wales, 2028, Australia
Conditions
Explore the condition pages connected to this study.